Literature DB >> 33584332

LncRNA H19 as a Competing Endogenous RNA to Regulate AQP Expression in the Intestinal Barrier of IBS-D Patients.

Guanqun Chao1, Zhaojun Wang2, Yi Yang2, Shuo Zhang2.   

Abstract

OBJECTIVE: The study aimed to investigate the role of Long non-coding RNA (LncRNA) H19 in the pathogenesis of Diarrhea Irritable Bowel Syndrome (IBS-D), and further to the regulatory effect of LncRNA H19 on AQP1, 3 in the intestinal mucosa of IBS-D patients, so as to seek a new way to elucidate the mechanism of IBS in clinic.
METHODS: The levels of LncRNA H19, AQP1, and AQP3 were detected in colonic tissues of IBS-D patients, compared with that in healthy controls. Through RNA gene interference and activation methods, small activating RNA (saRNA) and small interfering (siRNA) were transfered into Caco-2 cells in vitro experiment, and sub-group for two control group, siH19 empty vector group, siH19 interference group, overexpression H19 vector group, and overexpression H19 empty vector group. Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot were applied to evaluate the expression levels of LncRNA H19 and the amount of AQP1 and AQP3 protein expression, respectively.
RESULTS: Compared with healthy volunteers, the levels of LncRNA H19, AQP1, and AQP3 in the colonic mucosa of IBS-D patients were significantly decreased (P < 0.05). The results in vitro transfection experiment revealed that the level of LncRNA H19 in the siH19 interference group was significantly declined (P < 0.05), while there was a remarkable increase in the overexpression H19 vector group (P < 0.05), compared with the corresponding control groups. The expression of AQP1 and AQP3 in Caco-2 cells was of positive correlation with the level of LncRNA H19.
CONCLUSION: That the down-regulation of LncRNA H19 resulted in the expression changes of AQP1 and AQP3 may play an important role in the occurrence and development of IBS-D.
Copyright © 2021 Chao, Wang, Yang and Zhang.

Entities:  

Keywords:  AQP1; AQP3; IBS-D; LncRNA H19; mechanism

Year:  2021        PMID: 33584332      PMCID: PMC7874183          DOI: 10.3389/fphys.2020.602076

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  28 in total

1.  Irritable Bowel Syndrome-Type Symptoms Are Associated With Psychological Comorbidity, Reduced Quality of Life, and Health Care Use in Patients With Inflammatory Bowel Disease.

Authors:  David J Gracie; Alexander C Ford
Journal:  Gastroenterology       Date:  2017-05-29       Impact factor: 22.682

2.  lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy.

Authors:  Anu A Thomas; Saumik Biswas; Biao Feng; Shali Chen; John Gonder; Subrata Chakrabarti
Journal:  Diabetologia       Date:  2019-01-05       Impact factor: 10.122

3.  LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway.

Authors:  J-X Pan
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-01       Impact factor: 3.507

4.  Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.

Authors:  Qiuke Hou; Shuilian Zhu; Changrong Zhang; Yongquan Huang; Yajuan Guo; Peiwu Li; Xinlin Chen; Yi Wen; Quanbin Han; Fengbin Liu
Journal:  Biomed Pharmacother       Date:  2019-07-12       Impact factor: 6.529

5.  Defective dietary fat processing in transgenic mice lacking aquaporin-1 water channels.

Authors:  T Ma; S Jayaraman; K S Wang; Y Song; B Yang; J Li; J A Bastidas; A S Verkman
Journal:  Am J Physiol Cell Physiol       Date:  2001-01       Impact factor: 4.249

6.  Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.

Authors:  Shan-Wen Chen; Peng-Yuan Wang; Yu-Cun Liu; Lie Sun; Jing Zhu; Shuai Zuo; Ju Ma; Teng-Yu Li; Jun-Ling Zhang; Guo-Wei Chen; Xin Wang; Qiu-Ru Zhu; You-Wen Zheng; Ze-Yang Chen; Zi-Hao Yao; Yi-Sheng Pan
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

7.  H19 Long Noncoding RNA Regulates Intestinal Epithelial Barrier Function via MicroRNA 675 by Interacting with RNA-Binding Protein HuR.

Authors:  Tongtong Zou; Suraj K Jaladanki; Lan Liu; Lan Xiao; Hee Kyoung Chung; Jun-Yao Wang; Yan Xu; Myriam Gorospe; Jian-Ying Wang
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

8.  Disruption of imprinting caused by deletion of the H19 gene region in mice.

Authors:  P A Leighton; R S Ingram; J Eggenschwiler; A Efstratiadis; S M Tilghman
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

9.  Epidermal growth factor regulation by autophagy-mediated lncRNA H19 in murine intestinal tract after severe burn.

Authors:  Cuijie Li; Mengmeng Zhuang; Bo Zhu; Ye Li; Wenwen Zhang; Hao Yan; Pan Zhang; Dan Li; Juan Yang; Yuan Sun; Haijun Chen; Qingwei Cui; Peisheng Jin; Yong Sun
Journal:  J Cell Mol Med       Date:  2020-04-16       Impact factor: 5.310

10.  Study of the Mechanism Underlying the Onset of Diabetic Xeroderma Focusing on an Aquaporin-3 in a Streptozotocin-Induced Diabetic Mouse Model.

Authors:  Nobutomo Ikarashi; Nanaho Mizukami; Risako Kon; Miho Kaneko; Ryogo Uchino; Izumi Fujisawa; Natsuko Fukuda; Hiroyasu Sakai; Junzo Kamei
Journal:  Int J Mol Sci       Date:  2019-08-02       Impact factor: 5.923

View more
  3 in total

1.  Early and Late Transcriptional Changes in Blood, Neural, and Colon Tissues in Rat Models of Stress-Induced and Comorbid Pain Hypersensitivity Reveal Regulatory Roles in Neurological Disease.

Authors:  Evelina Mocci; Taichi Goto; Jie Chen; Seth Ament; Richard J Traub; Susan G Dorsey
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-17

Review 2.  The Role of lncRNAs in Regulating the Intestinal Mucosal Mechanical Barrier.

Authors:  Shanshan Chen; Chi Zhang; Beihui He; Ruonan He; Li Xu; Shuo Zhang
Journal:  Biomed Res Int       Date:  2021-11-15       Impact factor: 3.411

3.  Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.

Authors:  Azza Elamir; Olfat Shaker; Marwa Kamal; Abeer Khalefa; Mostafa Abdelwahed; Fadwa Abd El Reheem; Tarek Ahmed; Essam Hassan; Shymaa Ayoub
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.